Clik here to view.
Kadmon Announces Approximately $23 Million Equity Financing
Wednesday, March 8th 2017 at 2:06pm UTC NEW YORK–(BUSINESS WIRE)– Kadmon Holdings, Inc. (NYSE: KDMN) (“Kadmon”), a fully integrated biopharmaceutical company focused on developing innovative products...
View ArticleClik here to view.
Patent Trials and Appeal Board (PTAB) Upholds Four AMPYRA® Patents
Thursday, March 9th 2017 at 8:43pm UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq: ACOR ) today announced that the United States Patent and Trademark Office (USPTO) Patent Trials...
View ArticleClik here to view.
Success of AlgaPrime™ DHA in Aquaculture Market Drives Increased Commercial...
Wednesday, March 8th 2017 at 9:01pm UTC Expansion of Agreement with BioMar Signals Further Industry Adoption SAN FRANCISCO & WHITE PLAINS, N.Y.–(BUSINESS WIRE)– TerraVia (NASDAQ: TVIA), Bunge...
View ArticleClik here to view.
Bristol-Myers Squibb Appoints Dr. Thomas J. Lynch, Jr., Executive Vice...
Wednesday, March 8th 2017 at 5:24pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) today announced that it has appointed Dr. Thomas J. Lynch, Jr., 56, executive vice president...
View ArticleClik here to view.
22nd Century Group Files 2016 Annual Report and Announces Conference Call to...
Wednesday, March 8th 2017 at 9:29pm UTC CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is focused on tobacco harm reduction and cannabis...
View ArticleClik here to view.
Bristol-Myers Squibb to Take Part in Barclays Global Health Care Conference
Wednesday, March 8th 2017 at 2:00pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will present at Barclays Global Health Care Conference on Wednesday, March 15, 2017, in Miami....
View ArticleClik here to view.
Servier and Pfizer Announce FDA Clearance of IND Application for UCART19 in...
Thursday, March 9th 2017 at 7:00am UTC NEW YORK–(BUSINESS WIRE)– Regulatory News: Servier, together with Pfizer Inc. (NYSE:PFE) and Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS; Nasdaq:...
View ArticleClik here to view.
Enzo Biochem Re-Schedules Teleconference to Discuss Second Quarter 2017...
Monday, March 13th 2017 at 4:16pm UTC NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ), has rescheduled its planned conference call to discuss fiscal 2017 second quarter results for this...
View ArticleClik here to view.
Synergy Pharmaceuticals to Present at Oppenheimer 27th Annual Healthcare...
Tuesday, March 14th 2017 at 12:30pm UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced that Marino Garcia, the company’s EVP and Chief Strategy Officer, will...
View ArticleClik here to view.
Verastem to Present at the Oppenheimer 27th Annual Healthcare Conference
Wednesday, March 15th 2017 at 8:05pm UTC BOSTON–(BUSINESS WIRE)– Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced that the company will...
View ArticleClik here to view.
NOWDiagnostics Honored as Finalist in the 2017 Medical Design Excellence Awards
Wednesday, March 15th 2017 at 2:15pm UTC NOWDiagnostics cited for its role as a manufacturer of rapid point-of-care tests SPRINGDALE, Ark.–(BUSINESS WIRE)– NOWDiagnostics Inc. announced today that its...
View ArticleClik here to view.
Pfizer Launches Zavicefta™ (ceftazidime-avibactam) in the U.K. and Germany, a...
Tuesday, March 14th 2017 at 9:00am UTC Zavicefta™ Launches Address Urgent Medical Need for New Antibiotics NEW YORK–(BUSINESS WIRE)– Pfizer Inc. today announced that Zavicefta, a novel combination...
View ArticleClik here to view.
Enzo Biochem Reports Increased Second Quarter Operating Results
Monday, March 13th 2017 at 8:05pm UTC Long-term Strategy to Expand Laboratories Services Nationally Underway NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ) today reported continued strong...
View ArticleClik here to view.
Ajay Verma, M.D., Ph.D. Joins the Top Ranks of United Neuroscience to Help...
Tuesday, March 14th 2017 at 12:00pm UTC Dr. Verma Brings Deep Expertise in the Advancement of Neurotherapeutics to His New Role as Chief Medical Officer NEW YORK–(BUSINESS WIRE)– United Neuroscience,...
View ArticleClik here to view.
Catabasis Pharmaceuticals to Present at Oppenheimer’s 27th Annual Healthcare...
Wednesday, March 15th 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that Jill C....
View ArticleClik here to view.
Deciphera Pharmaceuticals to Present at 27th Annual Oppenheimer Healthcare...
Thursday, March 16th 2017 at 11:30am UTC WALTHAM, Mass.–(BUSINESS WIRE)– Deciphera Pharmaceuticals, a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug...
View ArticleClik here to view.
Teva Announces Launch of Authorized Generic of Minastrin® 24 Fe...
Thursday, March 16th 2017 at 5:58pm UTC JERUSALEM–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of the Authorized Generic of Minastrin® 24 Fe1...
View ArticleClik here to view.
Pfizer Announces Approval By The China Food And Drug Administration Of...
Thursday, March 16th 2017 at 1:00am UTC BEIJING–(BUSINESS WIRE)– Pfizer China announced today that it has received approval from the Chinese Food and Drug Administration (CFDA) to market its oral...
View ArticleClik here to view.
IRX Therapeutics’ Board of Directors Announces New Senior Management...
Thursday, March 16th 2017 at 11:00am UTC NEW YORK–(BUSINESS WIRE)– IRX Therapeutics, Inc. (IRX) announced today that the Company’s Board of Directors has appointed Mark Leuchtenberger, as President,...
View ArticleClik here to view.
Global Healthy Living Foundation Celebrates New FOURIER trial results...
Friday, March 17th 2017 at 1:00pm UTC Enthusiasm Tempered by Barriers Patients Face Accessing Evolocumab As Health Insurers Repeatedly Deny Prescription Claims UPPER NYACK, N.Y.–(BUSINESS WIRE)– The...
View Article